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Abstract 
 It has become clear in recent years that the human intestinal microbiota plays an important 
role in maintaining health and thus is an attractive target for clinical interventions. Scientists and 
clinicians have become increasingly interested in assessing the ability of probiotics and prebiotics to 
enhance the nutritional status of malnourished children, pregnant women, the elderly and 
individuals with non-communicable disease-associated malnutrition. A workshop was held by the 
International Scientific Association for Probiotics and Prebiotics (ISAPP), drawing on the knowledge 
of experts from industry, medicine and academia, with the objective to assess the status of our 
understanding of the link between the microbiome and under-nutrition, specifically in relation to 
probiotic and prebiotic treatments for under-nourished individuals. These discussions led to four 
recommendations: 1) The categories of malnourished individuals need to be differentiated. To 
improve treatment outcomes, subjects should first be categorised based on the cause of 
malnutrition, additional health-concerns, differences in the gut microbiota and sociological 
considerations 2) Define a baseline ‘healthy’ gut microbiota for each category. Altered nutrient 
requirement (for example, in pregnancy and old age) and individual variation may change what 
constitutes a healthy gut microbiota for the individual. 3) Perform studies using model systems to 
test the effectiveness of potential probiotics and prebiotics against these specific categories. These 
should illustrate how certain microbiota profiles can be altered, as members of different categories 
may respond differently to the same treatment. 4) Perform robust well-designed human studies 
with probiotics and/or prebiotics, with appropriate, defined primary outcomes and sample size. 
These are critical to show efficacy and understand responder and non-responder outcomes.  It is 
hoped that these recommendations will lead to new approaches that combat malnutrition.  
 This report is the result of discussion during an expert workshop titled “How do the 
microbiota and pro/prebiotics influence poor nutritional status?” held during the 10th Meeting of 
the International Scientific Association for Probiotics and Prebiotics (ISAPP) in Cork, Ireland from 
October 1-3, 2012. The complete list of workshop attendees is shown in Table 1.  
 
 
Introduction 
Malnutrition is a term that is generally used to cover both under-nutrition and over-
nutrition. It can be caused when an individual is (a) not getting enough food, (b) not getting the right 
sorts of food, or (c) not digesting and/or absorbing nutrients efficiently. Under-nutrition is one of the 
most serious problems affecting global health. The Food and Agriculture Organisation of the United 
Nations (FAO) estimates that about 870 million people were undernourished in the 2010-12 period, 
representing 12.5 percent of the global population. Of these cases, 852 million were in the 
developing world, corresponding to 14.9 percent of those populations. For the developing world as a 
whole, undernourishment had dropped significantly in the period 1990-2010 (23.2 to 14.9 percent), 
but in certain areas the contrary was true.  Most notably, the prevalence of undernourishment in 
sub-Saharan Africa increased from 17.0 to 27.0 percent 1. Clearly new innovative strategies are 
required to tackle this issue.  
Probiotics and prebiotics have been investigated for many years for their potential to 
improve digestive functions and to mitigate the effects of infectious and inflammatory conditions. 
Probiotics are ‘live microorganisms which when administered in adequate amounts confer a health 
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benefit on the host’ 2. Prebiotics are non-digestible carbohydrates which are selectively fermented 
by the gut microbiota, leading to improvements in health outcomes 3. Although the last few years 
have seen data emerge from many prebiotic human studies, a search of the Cochrane Library, 
Pubmed and Scopus did not reveal any meta-analysis on malnutrition and there is general lack of 
prebiotic population-based studies 4. There have however been several reviews and meeting reports 
highlighting the ability of prebiotics to alter the gut microbiota 4-8. A review published in 2012 
assessed the efficacy of probiotics in treating eight distinct gastrointestinal disease states 9. The 
meta-analysis of 74 randomised, placebo controlled studies showed an overall benefit of probiotic 
treatment. The magnitude of the effect varied between studies, possibly due to strain and 
formulation differences 9. Research into the mechanisms of action and benefits of probiotics and 
prebiotics provides us with a stepping-stone for discovering new ways in which they could improve 
human health. One area where probiotic and prebiotic research may be especially useful is in 
preventing repeated episodes of diarrhoea. Repeated incidences of lengthy episodes of diarrhoea 
can contribute to malnutrition due to enteropathy with ineffective energy and nutrient absorption. 
In recent years, attention has turned to ascertaining if probiotics and/or prebiotics could be used to 
improve the nutritional status of malnourished individuals.  
 A Cochrane Review on probiotics for acute infectious diarrhoea 10, found 63 randomised and 
quasi-randomised, placebo-controlled trials. These studies comprised 8014 participants from various 
geographical areas, in a wide range of settings; and also varied greatly in organisms tested, dosage 
supplied, and participants’ characteristics. Despite these variations, the vast majority of the trials 
showed a reduction in diarrhoea duration following probiotic treatment compared to controls, 
although effect sizes were highly variable between trials. The authors concluded that the difference 
in effect size was not explained by the known variables (study quality, probiotic strain, the number 
of different strains, the viability of the organisms, dosage of organisms, the causes of diarrhoea, or 
the severity of the diarrhoea, or whether the studies were done in developed or developing 
countries) 10. Recently acquired knowledge about the high level of inter-individual variation in the 
human gut microbiota may partially explain these different responses.  
 The human gut microbiota consists of >1000 bacterial species, with every individual host to 
at least 160 different species 11-13. This represents a genetic repertoire >150 fold larger than the 
Homo sapiens hosts’ complement 14. Although the exact assortment of bacterial species in the gut 
varies greatly among individuals, subjects from the same geographical region tend to have more 
similar bacterial communities than those from different regions 15, 16. This clustering is thought to be 
highly influenced by the diet 15.Therefore, when designing nutritional interventions for malnourished 
individuals, it is important to select specific strategies for the cohort being targeted.  
The objective of the workshop was to assess the status of our understanding of the link 
between the microbiome and under-nutrition, specifically in relation to probiotic and prebiotic 
treatments for under-nourished individuals. 
 
Micronutrient Absorption 
 
As well as improving nutritional status by mitigating the effects of diarrhoea, there is 
growing evidence that probiotics and prebiotics could be used to improve the absorption of 
micronutrients (such as calcium and iron) from ingested foods. Micronutrients are organic or 
inorganic compounds present in food in small amounts, such as vitamins or minerals, which are not 
used for energy but are nonetheless essential for good health 17. It is estimated that at least two 
billion people around the world are living with micronutrient deficiencies 18. The majority of these 
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are impoverished and are not consuming sufficient nutrient-rich foods. In the long term, nations will 
need to address how to improve nutritional strategies. In the short term, however, nutritional 
interventions delivered through many channels, including humanitarian efforts, will save many lives; 
as well as improve the health and cognitive capacity of millions of children 18-23. Probiotics and 
prebiotics increase bioavailability of micronutrients through several mechanisms and therefore 
represent an avenue for potentially alleviating micronutrient deficiencies.  
 
 The ability of prebiotics to increase micronutrient absorption has been examined and, 
although the effects were not uniform among all experiments, studies in both humans and animals 
showed positive effects of non-digestible oligosaccharides on mineral metabolism, bone 
composition and bone architecture 24-28. The increased short-chain fatty acid production due to 
prebiotic fermentation decreases the pH, increases mineral solubility and enlarges the enterocyte 
absorption surface. Some probiotics also appear to enhance micronutrient absorption (particularly 
calcium and iron) and bone development, but the effects appear to be highly dependent on the 
probiotic strain 24, 29-35. One placebo controlled study 34 showed that the iron status in young children 
could be improved significantly by intake of a milk-fortified with synbiotics (Bifidobacterium lactis 
HN019, oligosaccharide) for one year. Furthermore, the absorption of iron was improved 
significantly in healthy women of childbearing age after intake of probiotics (Lactobacillus plantarum 
299v) in a placebo cross–over controlled meal study 33. Since a large variety of probiotic strains, 
techniques, animal models and patient groups have been used in these experiments, it is impossible 
to draw general conclusions. Clearly, there is a need for more double-blind, randomised, placebo-
controlled human studies for specific subpopulations before we can assess the full potential of 
probiotics and prebiotics to improve the health status of individuals suffering from micronutrient 
deficiencies.  Ideally, several studies using the same protocols and strains or supplements, in specific 
patient categories would provide better insight.    
 
In some cases probiotic bacteria can have very specific beneficial effects, such as in the case 
of B-group vitamin production. Although B-group vitamins are present in many foods, they are easily 
removed or destroyed by food processing and cooking, which can lead to inadequate quantities 
being obtained from the diet. Genome sequencing has shown that Lactobacillus reuteri strains ATCC 
PTA 6475 and ATCC 55730   have biosynthetic pathways for Vitamin B12 and folate synthesis, and L. 
reuteri strain ATCC 55730 additionally possesses those for thiamine synthesis 36. Folate synthesis has 
been also characterized in several other microorganisms including some bifidobacteria strains 37. 
Further B-group vitamin-producing strains can be identified based on roseoflavin-resistance 
selection. Roseoflavin is a toxic riboflavin analogue shown to select for spontaneous mutations in 
Bacillus subtilis strains with constitutive over production of riboflavin 38. Several natural riboflavin 
overproducers have been described:  Lactococcus lactis 39, L. plantarum, Leuconosctoc 
mesenteroides and Propionibacterium freudenreichii 40, 41. Microbially produced vitamins thus 
represent a possible means of fortifying foods with additional micronutrients. This has been shown 
to be effective in rats fed a riboflavin-deficient diet. Most of the manifestations of ariboflavinosis (a 
medical condition caused by riboflavin-deficiency) observed in the riboflavin-deficient rats were 
eliminated when the diet was supplemented with milk fermented by L. lactis pNZGBAH – a strain 
that overproduces riboflavin during fermentation. This effect was not seen with milk fermented by a 
non-riboflavin-producing bacterial strain 42. 
 
Malnourished Children 
5 
 
The World Health Organisation (WHO) defines severe acute malnutrition (SAM) in childhood 
as a weight-for-height z-score (WHZ) of below -3 of the median WHO growth standards, by visible 
severe wasting, or by the presence of nutritional oedema (kwashiorkor). Over 13 million children 
suffer from SAM under the age of 5 years and 1 to 2 million die each year 43. Fatality rates of 
individuals undergoing hospital treatments for SAM are estimated at 20-30%, but have been known 
to be as high as 50-60%. These fatality rates have changed little over the last 50 years 44. Childhood 
under-nutrition also has long-term health consequences through programming for later disease, 
including the aberrant development of the immune system and cognitive function, generating 
enhanced risks of subsequent coronary heart disease and diabetes, and even excessive weight gain 
45. New treatments with earlier interventions are needed, even though early diagnosis of 
malnutrition is difficult, to prevent the development of SAM and reduce the burden of disease 
related to under-nutrition. 
Studies involving Indian children have shown that specific probiotics can significantly reduce 
the duration (combinations: Lactobacillus casei DN-114001, Lactobacillus bulgaricus and 
Streptococcus thermophilus; and L. lactis, L. lactis cremoris and Leuconostoc mesenteroides cremoris) 
46 and occurrence (L. casei strain Shirota and Lactobacillus acidophilus) 47, 48 of diarrhoea, and 
significantly increase the weight and height (L. acidophilus) of these children, relative to those fed a 
supplement with similar caloric value, but lacking probiotics 47. The success of these studies raises 
the possibility of using probiotics (and/or prebiotics) to improve the outcomes of nutritional 
interventions in the treatment of undernourished children. 
The PRONUT study 49 examined the ability of a mixture of four putative probiotic bacteria 
(Pediococcus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subsp. paracasei and 
L. plantarum) and four putative prebiotic substrates (inulin, pectin, oat bran and resistant starch) to 
improve the outcome of nutritional interventions for Malawian children admitted to hospital 
suffering from SAM. This mixture was added to a high-energy and nutrient dense, ready-to-use  
therapeutic food (RUTF), formulated to the WHO standards for SAM treatment 50. This was a double-
blind, randomised, placebo-controlled trial, involving 795 children, almost half of whom were HIV 
seropositive. Although no significant differences were seen over those in the control therapeutic 
food intake, the study highlighted some interesting points which should be considered for future 
studies. The first point was that these probiotics appear to be safe to use in HIV infected and 
immunodeficient malnourished children. There had been concerns that, due to the high prevalence 
of HIV in these subjects, probiotic administration might cause sepsis due to the 
immunocompromised status 51. However, no cases of probiotic-related bacteraemia were identified, 
despite blood cultures being available for sick children in both treatment arms 50. Secondly, it is 
important to consider that probiotics and prebiotics tested in one human population may have 
different effects on the gut microbiota of people living in different geographical locations and with 
distinct diets. Thirdly, the specific interactions between probiotic bacteria and prebiotics combined 
in a single mixture, and how they contribute to probiotic survival in the host, have rarely been 
studied.  In the PRONUT study, the inability of the mix to cause benefit did not mean that a different 
mix with greater amounts of the same or different probiotic bacteria might not have had an effect. 
Designing interventions without considering these and other issues may diminish the number of 
subjects who respond to treatment 52. Finally, interventions for severely malnourished children need 
to consider the effects of the probiotic and prebiotic therapy, compared to the standard nutrient 
rich food, which itself has a positive benefit.   
Another study, involving 317 Malawian twin pairs in the first three years of life, 
characterized the gut microbiome of twin pairs discordant for kwashiorkor, during and after 
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treatment with RUTF.  A model of gnotobiotic mice was used to test the effectiveness of the same 
nutritional intervention 53, following transplantation of frozen faecal communities from three twin 
pairs, with one twin from each pair suffering from kwashiorkor, into germ-free mice 53. The animals 
were then fed the low-caloric density and nutrient-deficient diet similar to that of Malawian 
children. After 3 weeks, their diet was switched to the high energy, micronutrient rich RUTF for 2 
weeks and then switched back to the initial Malawian diet. The authors reported a profound 
difference in weight change between mice transplanted with healthy and kwashiorkor faecal 
communities, with a more dramatic change in body weight when switching between diets in 
kwashiorkor mice than in the healthy control mice 53. This study would suggest that there are 
clinically important differences in the gut microbiota of children who develop kwashiorkor, which 
may determine the response to dietary change. The study also indicates that gnotobiotic mice, 
transplanted with the faecal communities of different groups, might be a valuable model in devising 
individualised dietary interventions. 
Malnourished Pregnant Women  
Pregnant women are among the most nutritionally vulnerable groups due to their increased 
nutrient requirements 54. In developing countries, poverty often limits the quantity, and quality, of 
food available, placing a further nutritional burden on pregnant women. In addition, the seasonal 
deterioration of nutritional status due to food shortages and an increase in agricultural labour (often 
coinciding with seasonal endemic diseases) further affects their nutritional status 55, with annual 
cycles of weight gain and loss. A report published by the LINKAGES project revealed that these 
factors result in 5-20 percent of women in various African countries being underweight. The report 
also indicates that micronutrient deficiencies (particularly iron, vitamin A, zinc, folic acid, riboflavin, 
and iodine) are common in pregnant African women 56. This can result in increased risk of mortality 
from severe anaemia and eclampsia for the mothers; and premature delivery and low-birth weight 
babies 57. 
 
 Mechanisms to improve maternal and childhood nutrition in the developing world include 
initiatives to set up sustainable kitchens to provide fermented milk products to the local community. 
This provides employment for the mothers, and much-needed nutrient-rich food for the children 
and adults. A study in Mwanza, Tanzania,  evaluated the ability of a probiotic-containing and 
micronutrient-fortified yogurt that could be locally produced, to improve the nutritional status of 
pregnant women.  The yogurt was produced from locally sourced milk, to which 2% standard yogurt 
cultures (Lactobacillus delbrueckii subsp. bulgaricus and S. thermophilus) and 4% probiotic culture 
Lactobacillus rhamnosus GR-1 were added. Since the costs of importing the micronutrients 
supplemented to the yogurt in the two previous studies were too high to be sustainable in Sub-
Saharan Africa, a locally available food source (the leaves of the Moringa oleifera plant) was added 
to the yogurt as a source of vitamin A, C, zinc and iron. This study is a noteworthy example of 
customising treatment to suit the target group (Gregor Reid, personal communication). The 
outcomes of this study have yet to be published, but the development of a probiotic food in a locally 
sustainable way shows that such interventions are indeed feasible in resource disadvantaged areas 
like Sub-Saharan Africa 60. This study was prompted by two previous studies by the same group. The 
first study involved a micronutrient enriched probiotic yogurt containing various added vitamins and 
minerals that was found to be safe for use in Tanzanian subjects and improved haemoglobin levels 
58. The second was a Canadian study of HIV infected adults on anti-retroviral therapy, in which the 
same enriched yogurt improved the CD4 cell count and had no adverse effects 59. 
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A recent study involving 91 pregnant women suggests that the gut microbiota is profoundly 
altered during pregnancy 61. The microbial composition changed markedly between the first and 
third trimesters, with an increase in the relative abundances of Proteobacteria and Actinobacteria in 
69.5% and 57% of women, respectively.  There was also a decrease in the overall bacterial diversity 
as women progressed from the first to the third trimester 61. The authors argue that these 
alterations are a mechanism by which the gut microbiota can promote weight gain, thus providing 
energy for foetal growth. If this is the case, then there is a need to define what constitutes a healthy 
gut microbiota for pregnant women, as the microbial composition by the third trimester resembles a 
disease-associated dysbiosis in non-pregnant women 61. None of the pregnant women enrolled in 
that study were under-nourished, and further work would be required to determine whether the 
same reduction in bacterial diversity occurs during pregnancy when adequate nutrition is not 
available. 
Malnourished Elderly 
 By the end of this decade, it is estimated that in many countries for the first time the 
proportion of people over the age of 65 years will be greater than those under the age of 5 years 62. 
As the global population grows older, maintaining the health of elderly individuals becomes 
increasingly more important, and as medical expenditure is highest during the later years of life, the 
ability to maintain the health of elderly individuals becomes critical for economic reasons. Older 
consumers present paradoxical nutrition-related challenges; malnutrition is increasingly prevalent in 
this age group, even in developed societies such as the European Union 63. At the same time, obesity 
in older people in western countries is following the same increasing trend for younger adults 64. 
Recent studies have revealed that the composition of the gut microbiota changes markedly with age, 
and elderly individuals (>65 years) tend to have greater inter-individual variation than younger 
adults. Additionally, there is a general decrease in species diversity 
for Bacteroides, Prevotella, Bifidobacteria, and Lactobacillus spp., and an increase in species 
numbers within the Enterobacteriaceae, staphylococci, streptococci groups, and Candida albicans, 
relative to healthy young adults 65-68. This altered microbial community may be pro-inflammatory, 
and the presence of inflammatory markers correlates to frailty 69. Changes in the composition of the 
gut microbiota in elderly individuals have been linked to poorer health and nutritional status, and 
correlated with habitual diet, particularly comparing older subjects living in their own homes with 
those living in long-term residential care facilities 70. Metagenomic analysis showed that these diet-
microbiota composition differences between residence location groups were also reflected in the 
genetic capacity of the microbiota for producing short-chain fatty acids such as butyrate and 
propionate, which are important energy sources and signalling molecules in the intestine 70.The gut 
microbiota may therefore represent an attractive target for improving nutritional status in 
malnourished elderly individuals. Increasing the diversity of the general diet, and including probiotic 
and prebiotic products, could be a simple and affordable way of modulating the intestinal microbiota 
of older people to promote beneficial microbial metabolism. In the last decade, there have been 
several human studies evaluating the potential of prebiotics and probiotics to improve the health of 
the elderly, generally by modulating the gut microbiota composition 71-75. Prebiotic intervention in 
frail elderly individuals increased the prevalence of bifidobacteria but also reduced the levels of pro-
inflammatory cytokines such as IL-6, and improved immune status, even after treatment ended 76. In 
this study there was a distinction between responders and non-responders, which needs further 
investigation, and which may be related to specific populations of gut bacteria in the subjects prior 
to the intervention. This phenomenon has been demonstrated in a study showing a differential 
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response of the gut microbiota of younger adults to resistant starch, depending on their starting 
microbiota 12. 
 
 The application of metagenomics elucidates the relationships between different microbiota 
compositions and genetic capacities, and health statuses in the elderly 70. This approach circumvents 
functional redundancy in a way that microbial composition studies cannot. This enables a more 
logical approach to designing intervention studies, which aim to improve the microbial metabolic 
output. Physiological changes that occur as individuals become elderly should also be considered: for 
example, the decline in cutaneous levels of 7-dehydrocholesterol means that there is a reduced 
synthesis of cholecalciferol (vitamin D) after exposure to the sun. This decline, combined with an 
increase in body fat, contributes to the high prevalence of vitamin D deficiencies in the elderly. This 
in turn, lowers calcium and phosphate absorption 77 potentially contributing to osteoporosis. 
Therefore, the altered requirements of the elderly should be considered when attempting to 
optimise the microbiota for their health. Reduced diversity of the gut microbiota in older subjects 
correlates with susceptibility to Clostridium difficile infection 78, and the Bifidobacterium element of 
low-diversity microbiota of older subjects in long-term residential care is also more susceptible to 
antibiotic therapy 79. Probiotic administration may therefore be indicated for these subjects. 
Undernourishment associated with non-communicable disease 
 
Malnutrition can also be associated with the presence of a non-communicable disease, such 
as anorexia nervosa (AN) or cancer, leading to cancer-related cachexia. There have been few studies 
to date investigating the potential for probiotics or prebiotics in alleviating the symptoms, signs and 
complications of these diseases. 
AN is a syndrome characterised by an intense fear of fatness, and the individual’s refusal to 
eat with the purpose of losing weight or maintaining it below normal standards. Severe situations of 
malnutrition can develop over time and high mortality rates are associated with the illness 80. AN 
patients exhibit an immunocompromised status that shares some characteristics with typical 
malnutrition, namely leukopenia and an impaired cell mediated immunity (for example depleted T 
cell subset counts and altered cytokine production in response to a stimulus) 81. Administration of 
yoghurt (milk fermented with L. delbreuckii subsp. bulgaricus and S. thermophilus) to AN patients 
was associated with increased interferon gamma production upon stimulation of isolated peripheral 
blood mononuclear cells. This enhanced immune response could be relevant in achieving an 
improved protection against pathogens 82. Genomic analysis of faecal microbiota in a few individuals 
with AN (N=9) has shown a higher proportion of methane producers (Methanobrevibacter smithii) 
than in lean controls, which might represent an adaptive mechanism allowing for an increase in the 
efficiency of nutrient utilization 83. 
Cachexia is the term used to describe the weight loss and malnutrition linked to debilitating 
chronic diseases. The inflammation associated with these is the result of an exaggerated immune 
response, and the mediators of this inflammatory response may cause the development of cachexia. 
Cancer cachexia is characterised by a significant reduction in body weight resulting predominantly 
from loss of adipose tissue and skeletal muscle. Cancer remains a major global health burden, and 
cachexia affects the majority of the patients with advanced disease 84, 85. There is much evidence 
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that malnourished cancer patients have a reduced survival; however, the corollary hypothesis, that 
reversal of nutritional deficits should extend survival, remains unproven 86. 
The gut microbiota composition is different between cancer patients under treatment and 
matched controls, and this is at least partially due to the administration of chemotherapeutic drugs 
and antibiotics. In paediatric patients with acute myeloid leukaemia, van Vliet and colleagues 87 
reported a 10,000-fold decrease in anaerobic bacteria and a 100-fold increase in potentially 
pathogenic enterococci. This disturbance in the gut ecosystem might influence colonization 
resistance and thereby favour infections by enteric diarrhoea-causing pathogens, which can affect 
nutrient absorption, aggravating malnutrition. 
Two studies published in 2012 highlighted that gut microbiome is modified in rodent models 
of cancer 88, 89. In the first study, the caecal microbiota composition was modified in leukemic mice 
with cachexia, and lactobacilli levels in the caecal content exhibited a 50-fold decrease. Interestingly, 
restoring lactobacilli levels using the putative probiotic bacteria L. reuteri 100-23 and L. gasseri 
311476 decreased systemic inflammation and atrophy markers in the muscle, two features of the 
cachexia syndrome 88. In the second study, an increase in Clostridium clusters I and IX and in 
Enterobacteriaceae was reported in faeces of rats subcutaneously implanted with a colon tumour. 
This study mainly aimed to analyse the impact of irinotecan, a chemotherapeutic drug, on intestinal 
microbiota. The authors proposed that the presence of the tumour induced greater changes in the 
microbiota than chemotherapy 89.  
Gastrointestinal complications constitute a major dose-limiting side effect of chemotherapy, 
promote overall malnutrition, aggravate cancer cachexia, and may contribute to a worsened 
prognosis.  More than 90% of chemotherapeutic drugs induce gastrointestinal toxicity. In this 
context, probiotics and prebiotics have been proposed as therapeutic factors that could potentially 
modulate gastrointestinal complications related to cancer treatments. Suggested mechanisms 
include improving colonization resistance and boosting gut barrier function, through the production 
of short chain fatty acids and intestinal hormones such as glucagon-like peptide 2 90.  
Recommendations 
The workshop discussion reflected the research background of the participants and their 
knowledge about the current uses of prebiotics and probiotics in the specific areas mentioned 
above. The following four recommendations are made with the aim of increasing the success of 
probiotic and prebiotic nutritional interventions in treating malnutrition:   
1) The categories of malnourished individuals need to be differentiated. To improve treatment 
outcomes, subjects should be categorised based on the cause of malnutrition, additional health-
concerns, differences in the gut microbiota and sociological considerations. The effectiveness of 
a treatment can be dramatically altered by the cause of malnutrition (lack of intake or lack of 
absorbance), additional health problems (HIV, other infections), differences in nutritional 
requirement (pregnancy and old age), differences in the gut microbiota (antibiotic treatment, 
alternative diet) and sociological considerations (treatment sustainability, seasonality, 
affordability). Appropriate categorisation may allow clarification of the responder and non-
responder phenomenon. 
2) Define a baseline ‘healthy’ gut microbiota for each category. There is evidence that the gut 
microbial composition is different in specific groups of individuals, in different geographical 
locations, and may even alter to accommodate changes in nutrient requirements, therefore 
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changing what defines a healthy gut microbiota for the individual. This appears to be the case in 
pregnant women, with the gut microbiota shifting to a composition that accommodates weight 
gain and the energy requirements essential for foetal growth. This may also be the case in the 
elderly, but studies investigating the metabolic consequences of the altered elderly microbiota 
are required.  
3) Perform studies using model systems to test the effectiveness of potential probiotics and 
prebiotics against these specific categories. The benefit to the host is specific to which pro- or 
pre-biotic (or combination of these) is used. Probiotics and prebiotics act primarily through 
modulation of the gut microbiota and by interacting directly with the host. If the gut microbial 
composition of one population is different from another, then it follows that different probiotics 
or prebiotics may be required. Therefore, laboratory studies analysing the efficacy of probiotics 
and prebiotics must take geographical differences in the human gut microbiota into account. 
4) Perform robust well-designed human studies with probiotics and/or prebiotics, with 
appropriate, defined primary outcomes and sample size.Ultimately, the knowledge gained from 
laboratory experimentation must be translated into treatments that improve the health 
outcomes of individuals suffering from undernourishment. This requires that comparable and 
high-quality trials be performed, with clinically relevant primary outcomes, rather than proxy 
laboratory markers. This may be achieved by conducting studies according to CONSORT 
guidelines 91. The controversy surrounding the efficacy of probiotics, in general, can be mainly 
attributed to the lack of clinical trials examining the ability of specific probiotic strains to 
alleviate the effects of specific diseases. This has resulted in meta-analyses averaging the 
efficacy results of different probiotics treatments against a specific disease 9, 92. This can 
generate misleading conclusions, as depending on the mechanism, the probiotic effect can be 
highly strain-specific. 
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